Global University Venturing

Sarepta Therapeutics provided $15m in a series A round for the company, which is advancing University of Florida research.

Incubated by Vision Institute, the retinal disease gene therapy developer has secured $52.8m in a round co-led by UPMC Enterprises.

QUB spinout ProAxsis has been fully acquired by NetScientific, which previously backed the company’s sole funding round in 2014.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The UC Berkeley spinout has been snapped up by Astellas, two years after the latter took part in its series A round.

TUM-affiliated UVC Partners has raised a third fund from limited partners including Lanxess to invest in industrial technologies, business-to-business software and mobility.

Utec was among the backers that helped University of Tokyo spinout Japan Data Science Consortium complete a $27.5m round.

Topas Therapeutics, which is exploiting University of Hamburg research, has pocketed $26m in its series B round.

Main Sequence Ventures, which co-founded the meat-free burger producer last year, has returned for a $55m series B round.

The computer vision chip producer is based on research at Tsinghua University and Chinese Academy of Sciences.